Catabasis Pharma (CATB) Tops Q3 EPS by 9c

Catabasis Pharma (NASDAQ: CATB) reported Q3 EPS of ($0.55), $0.09 better than the analyst estimate of ($0.64).

For earnings history and earnings-related data on Catabasis Pharma (CATB) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Range Impact, Inc. (RNGE) Reports Q2 Loss of $0.02
• Boxlight Corporation (BOXL) Tops Q2 EPS by 2050c